avVaa World Health Care Products (Pink Sheets: AVVH) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers and their pets. Corporate headquarters and operations are located in Richmond, Virginia.
The company has created two divisions of products that they have accomplished R&D on over the past decade based on avVaa’s patented European skin care formulas that are scientifically registered and were developed to relieve and treat the symptoms of common skin ailment; including dermatitis, psoriasis and acne for the human line.
The Company’s second line of its unique, high-quality therapeutic skin care products includes a comprehensive line of all natural Animal Care products which is a complete grooming treatment for dogs, cats, horses and other pets in one easy application and designed to capture a share of the $60 billion+ worldwide animal care products market.
The management team of avVaa World Health Care Products is strong in international sales, marketing, financial accounting, and banking experience. The Company’s focus has been redefined and directed to the Dermalustre animal care products line.
In the past the Corporation has focused on Research and Development in its three product divisions. Now with three lines of products the company has turned away from R&D and will focus time and monies to the markets, distribution and distributors. To make the company profitable and maximize funds available; the company will change its focus to bringing the dermalustre line to market one product line at a time. As the animal line is a minor market compared to the human line. This will lead to minimal to no marketing for the other products we carry for now; yet will allow avVaa to create sales in the market place with maximum funding and marketing support by the company.
To carry out the marketing strategies, avVaa will continue to build strong relationships with trade distributors (national and international) and end users to drive sales in the various market areas: direct consumer; institutional; clinical; mainstream retail and specialty merchants; private brand; and health and natural food stores.
The Company’s confidence in the effectiveness and safety of these proven products is founded in extensive data including European clinical trials and evaluation and research spanning over a decade. avVaa’s major goal is to provide a better quality of life for global customers by relieving the severe and underlying pain caused by skin disorders, developing products with high customer need and large patient populations, while at the same time generating substantial returns for investors.